FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, specifically to a body-contacting medicinal product such as a short-term implant and a long-term implant coated by at least one layer, which contains a molecular-disperse distributed or dissolved active substance in at least one carrier and optionally one or more additives; the above at least one layer is formed of abrasion-resistant solution in the form of a over-cooled melt, which optionally contains a crystallisation inhibitor.
EFFECT: coated implant makes it possible to transfer the active substance to vascular walls effectively and with no particles formed.
10 cl, 18 ex
Title | Year | Author | Number |
---|---|---|---|
MEDICAL DEVICE FOR TREATING LUMEN OBTURATIONS AND PREVENTING THREATENING RECURRENT OBTURATIONS | 2008 |
|
RU2447901C2 |
MEDICAL DEVICE FOR TREATING LUMEN OBTURATIONS AND PREVENTING THREATENING RECURRENT OBTURATIONS | 2008 |
|
RU2458710C2 |
BALLOON CATHETER COATED WITH ANTIRESTENOSIS ACTIVE INGREDIENT AND TRANSPORT PROMOTING MOLECULAR DISPERSING AGENT | 2011 |
|
RU2543330C2 |
BIODEGRADABLE DEVICE FOR VESSEL LUMEN MAINTENANCE | 2008 |
|
RU2452517C2 |
DISSOLVING STENTS CONTAINING MAGNESIUM ALLOYS | 2012 |
|
RU2642254C2 |
ENDOPROSTHESIS, COATED WITH ACTIVE COMPOUND | 2012 |
|
RU2592367C2 |
STENT | 2007 |
|
RU2432183C9 |
CATHETER CYLINDER | 2011 |
|
RU2633723C2 |
DEVICE FOR LOCAL AND/OR REGIONAL DELIVERY USING LIQUID FORMULATIONS OF THERAPEUTICALLY ACTIVE SUBSTANCES | 2009 |
|
RU2596092C2 |
DEVICE FOR LOCAL AND/OR REGIONAL DELIVERY USING LIQUID FORMULATIONS OF ACTIVE SUBSTANCES | 2009 |
|
RU2513153C2 |
Authors
Dates
2016-03-27—Published
2011-05-27—Filed